ApoE4 was also suggested to be less efficient than ApoE3 in transporting brain cholesterol [33], which may underly the reduction in cholesterol levels in patients with AD, particularly in hippocampal and cortical areas [35] that are highly affected in this pathology. This evidence concerns the gene APOE and Alzheimer disease.